Literature DB >> 10429661

Effect of 5-fluorouracil on cell cycle regulatory proteins in human colon cancer cell line.

H Takeda1, M Haisa, Y Naomoto, R Kawashima, K Satomoto, T Yamatuji, N Tanaka.   

Abstract

We investigated the effects of 5-fluorouracil (5-FU) on cell cycle-regulating proteins in RPMI 4788 cells. 5-FU inhibited cell growth dose-dependently and this growth inhibition was accompanied with cell cycle accumulation in early S phase and increased expression of cyclin A. When cells were released from short-term treatment (3 or 24 h) with 5-FU, the cell cycle started to progress again and cyclin A protein levels decreased. Cyclin A-associated kinase activity assay showed that cyclin A-cyclin-dependent kinase (Cdk) 2 kinase activity was altered by 5-FU treatment concomitantly with the changes in cell cycle state seen in flow cytometric analysis. Furthermore, the elevation of cyclin A protein level by 5-FU treatment was observed in three other human cancer cell lines, DLD-1, H226Br and T.Tn. These results suggest that cyclin A protein levels in cancer cells are increased by 5-FU, and the cyclin A function and degradation mechanism remain normal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10429661      PMCID: PMC5926118          DOI: 10.1111/j.1349-7006.1999.tb00800.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  Comparison of the effects of several inhibitors of the synthesis of nucleic acids upon the viability and progression through the cell cycle of cultured H. Ep. no. 2 cells.

Authors:  G P Wheeler; B J Bowdon; D J Adamson; M H Vail
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

2.  Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients.

Authors:  E Petit; G Milano; F Lévi; A Thyss; F Bailleul; M Schneider
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

Review 3.  Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

Review 4.  The pharmacology of the fluoropyrimidines.

Authors:  C E Myers
Journal:  Pharmacol Rev       Date:  1981-03       Impact factor: 25.468

5.  Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil.

Authors:  G Pizzorno; Z Sun; R E Handschumacher
Journal:  Biochem Pharmacol       Date:  1995-02-14       Impact factor: 5.858

6.  Association of human cyclin E with a periodic G1-S phase protein kinase.

Authors:  V Dulić; E Lees; S I Reed
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

7.  Cyclin A and Cdk2 kinase activity are suppressed by combined treatment with tumor necrosis factor-alpha and interferon-alpha.

Authors:  K Satomoto; M Haisa; Y Naomoto; N Tanaka; K Orita
Journal:  Biochem Biophys Res Commun       Date:  1995-08-24       Impact factor: 3.575

8.  5-Fluoro-2'-deoxyuridine incorporation in L1210 DNA.

Authors:  D W Kufe; P P Major; E M Egan; E Loh
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

9.  Flow cytometric analysis of cell-killing actions of 5-fluorouracil in human colorectal cancer cells.

Authors:  M Inaba; J Mitsuhashi
Journal:  Oncol Res       Date:  1994       Impact factor: 5.574

10.  Effects of the plasma concentration of 5-fluorouracil and the duration of continuous venous infusion of 5-fluorouracil with an inhibitor of 5-fluorouracil degradation on Yoshida sarcomas in rats.

Authors:  S Fujii; Y Shimamoto; H Ohshimo; T Imaoka; M Motoyama; M Fukushima; T Shirasaka
Journal:  Jpn J Cancer Res       Date:  1989-02
View more
  8 in total

Review 1.  Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.

Authors:  Barbara Vanhoecke; Emma Bateman; Bronwen Mayo; Eline Vanlancker; Andrea Stringer; Daniel Thorpe; Dorothy Keefe
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

2.  PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage.

Authors:  B H Huang; J L Zhuo; C H W Leung; G D Lu; J J Liu; C T Yap; S C Hooi
Journal:  Cell Death Dis       Date:  2012-12-13       Impact factor: 8.469

3.  Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.

Authors:  Paula M De Angelis; Debbie H Svendsrud; Katherine L Kravik; Trond Stokke
Journal:  Mol Cancer       Date:  2006-05-18       Impact factor: 27.401

4.  Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe?

Authors:  Kevin Dzobo; Naseeha Hassen; Dimakatso Alice Senthebane; Nicholas Ekow Thomford; Arielle Rowe; Hendrina Shipanga; Ambroise Wonkam; M Iqbal Parker; Shaheen Mowla; Collet Dandara
Journal:  Molecules       Date:  2018-04-17       Impact factor: 4.411

5.  Synthesis of Novel 2-Thiouracil-5-Sulfonamide Derivatives as Potent Inducers of Cell Cycle Arrest and CDK2A Inhibition Supported by Molecular Docking.

Authors:  Samar S Fatahala; Amira I Sayed; Shahenda Mahgoub; Heba Taha; Mohamed-I Kotb El-Sayed; Mohamed F El-Shehry; Samir M Awad; Rania H Abd El-Hameed
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

6.  Effects of small interfering RNA targeting thymidylate synthase on survival of ACC3 cells from salivary adenoid cystic carcinoma.

Authors:  Takashi Shirasaki; Shin-ichiro Maruya; Hiroki Mizukami; Seiji Kakehata; Hidekachi Kurotaki; Soroku Yagihashi; Hideichi Shinkawa
Journal:  BMC Cancer       Date:  2008-11-26       Impact factor: 4.430

7.  Improved cytotoxic effects of Salmonella-producing cytosine deaminase in tumour cells.

Authors:  Beatriz Mesa-Pereira; Carlos Medina; Eva María Camacho; Amando Flores; Eduardo Santero
Journal:  Microb Biotechnol       Date:  2014-09-16       Impact factor: 5.813

8.  The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.

Authors:  Yan Zhang; Jiangxia Fan; Yichao Fan; Lili Li; Xiaoqian He; Qin Xiang; Junhao Mu; Danfeng Zhou; Xuejuan Sun; Yucheng Yang; Guosheng Ren; Qian Tao; Tingxiu Xiang
Journal:  Clin Epigenetics       Date:  2018-02-27       Impact factor: 6.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.